SCHEMBL20021993

SCHEMBL20021993

CC(C)CNS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
GPR55 Q9Y2T6 1/20 0.62
MMP12 P39900 3/20 0.58
MMP1 P03956 3/20 0.58
GAA P10253 1/20 0.58
ADAMTS4 O75173 3/20 0.55
MMP2 P08253 5/20 0.54
MMP9 P14780 4/20 0.54
MMP8 P22894 2/20 0.54
MMP14 P50281 2/20 0.54
MMP3 P08254 3/20 0.54
MMP13 P45452 3/20 0.54
MMP7 P09237 2/20 0.54
GRIA4 P48058 2/20 0.54
ADAM17 P78536 1/20 0.54
MEP1B Q16820 1/20 0.54
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674105 0.89 ALDH1A1 (0.66) ALDH1A1GRIA4HSP90AA1HSP90AB1PDK1
Hydrochloric Acid SCHEMBL14638221 0.87 ALDH1A1 (0.64) ALDH1A1GAAGRIA4HSP90AA1HSP90AB1
SCHEMBL6326386 0.87 MMP1 (0.59) ALDH1A1GPR55MMP12MMP1GAA
SCHEMBL15087835 0.87 MMP1 (0.59) ALDH1A1GPR55MMP12MMP1GAA
SCHEMBL7260455 0.86 GBA1 (0.68) ALDH1A1GPR55MMP1GAAMMP2
SCHEMBL890706 0.85 ALDH1A1 (0.61) ALDH1A1MMP1GAAMMP2MMP9
SCHEMBL28129548 0.85 CA1 (0.71) ALDH1A1MMP1GAAMMP2MMP9
SCHEMBL890942 0.84 GPR55 (0.60) ALDH1A1GPR55MMP12MMP1GAA
SCHEMBL28719400 0.83 MMP2 (0.56) ALDH1A1MMP12MMP1GAAADAMTS4
SCHEMBL5870281 0.80 MMP2 (0.58) GPR55MMP12MMP1GAAADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527152-A Biphenylsulfonamide compound and method for preventing and treating crop pests by using same 西北农林科技大学 2021-10-22 CN claimed
CN-113527152-A Biphenylsulfonamide compound and method for preventing and treating crop pests by using same 西北农林科技大学 2021-10-22 CN disclosed
US-20180093960-A1 METHOD OF INHIBITING APOLIPOPROTEIN-E EXPRESSION WHILE INCREASING EXPRESSION OF AT LEAST ONE OF LDL-RECEPTOR PROTEIN OR ABCA1 PROTEIN COMPRISING ADMINISTERING A SMALL COMPOUND MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2018-04-05 US disclosed
US-20180093960-A1 METHOD OF INHIBITING APOLIPOPROTEIN-E EXPRESSION WHILE INCREASING EXPRESSION OF AT LEAST ONE OF LDL-RECEPTOR PROTEIN OR ABCA1 PROTEIN COMPRISING ADMINISTERING A SMALL COMPOUND MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093960-A1 METHOD OF INHIBITING APOLIPOPROTEIN-E EXPRESSION WHILE INCREASING EXPRESSION OF AT LEAST ONE OF LDL-RECEPTOR PROTEIN OR ABCA1 PROTEIN COMPRISING ADMINISTERING A SMALL COMPOUND LDLR, APOB, NR1H2 ALDH1A1 3152/4885GPR55 1266/4885MMP12 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.